{"count":13,"docs":"https://aiswingx.com/docs","items":[{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/RevenueFromContractWithCustomerExcludingAssessedTax","change":0.09532628826669572,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Revenue","label_en":"Revenue","label_ko":"\ub9e4\ucd9c","period_type":"duration","xbrl_tag":"RevenueFromContractWithCustomerExcludingAssessedTax"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/RevenueFromContractWithCustomerExcludingAssessedTax","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-38","unit":"USD","value":10054000000.0,"xbrl_fact_id":"f-38"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-39","unit":"USD","value":9179000000.0,"xbrl_fact_id":"f-39"}],"statement":"Amgen Inc. (AMGN) reported Revenue of USD 10,054,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/RevenueFromContractWithCustomerExcludingAssessedTax","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-38"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/OperatingIncomeLoss","change":0.3230421686746988,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Operating income","label_en":"Operating income","label_ko":"\uc601\uc5c5\uc774\uc775","period_type":"duration","xbrl_tag":"OperatingIncomeLoss"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/OperatingIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-62","unit":"USD","value":3514000000.0,"xbrl_fact_id":"f-62"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-63","unit":"USD","value":2656000000.0,"xbrl_fact_id":"f-63"}],"statement":"Amgen Inc. (AMGN) reported Operating income of USD 3,514,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/OperatingIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-62"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/NetIncomeLoss","change":0.6585195530726257,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Net income","label_en":"Net income","label_ko":"\uc21c\uc774\uc775","period_type":"duration","xbrl_tag":"NetIncomeLoss"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/NetIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-82","unit":"USD","value":2375000000.0,"xbrl_fact_id":"f-82"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-83","unit":"USD","value":1432000000.0,"xbrl_fact_id":"f-83"}],"statement":"Amgen Inc. (AMGN) reported Net income of USD 2,375,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/NetIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-82"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/IncomeTaxExpenseBenefit","change":1.8897058823529411,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Income tax","label_en":"Income tax","label_ko":"\ubc95\uc778\uc138","period_type":"duration","xbrl_tag":"IncomeTaxExpenseBenefit"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/IncomeTaxExpenseBenefit","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-78","unit":"USD","value":393000000.0,"xbrl_fact_id":"f-78"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-79","unit":"USD","value":136000000.0,"xbrl_fact_id":"f-79"}],"statement":"Amgen Inc. (AMGN) reported Income tax of USD 393,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/IncomeTaxExpenseBenefit","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-78"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/ShareBasedCompensation","change":-0.008264462809917356,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Stock-based compensation","label_en":"Stock-based compensation","label_ko":"\uc8fc\uc2dd\ubcf4\uc0c1","period_type":"duration","xbrl_tag":"ShareBasedCompensation"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/ShareBasedCompensation","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-278","unit":"USD","value":240000000.0,"xbrl_fact_id":"f-278"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-279","unit":"USD","value":242000000.0,"xbrl_fact_id":"f-279"}],"statement":"Amgen Inc. (AMGN) reported Stock-based compensation of USD 240,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/ShareBasedCompensation","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-278"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/NetCashProvidedByUsedInOperatingActivities","change":0.686461454644511,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Operating cash flow","label_en":"Operating cash flow","label_ko":"\uc601\uc5c5\ud65c\ub3d9 \ud604\uae08\ud750\ub984","period_type":"duration","xbrl_tag":"NetCashProvidedByUsedInOperatingActivities"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/NetCashProvidedByUsedInOperatingActivities","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-304","unit":"USD","value":6191000000.0,"xbrl_fact_id":"f-304"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-305","unit":"USD","value":3671000000.0,"xbrl_fact_id":"f-305"}],"statement":"Amgen Inc. (AMGN) reported Operating cash flow of USD 6,191,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/NetCashProvidedByUsedInOperatingActivities","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-304"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/PaymentsToAcquirePropertyPlantAndEquipment","change":0.5705128205128205,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Capex","label_en":"Capex","label_ko":"\uc124\ube44\ud22c\uc790","period_type":"duration","xbrl_tag":"PaymentsToAcquirePropertyPlantAndEquipment"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/PaymentsToAcquirePropertyPlantAndEquipment","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-306","unit":"USD","value":1225000000.0,"xbrl_fact_id":"f-306"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-307","unit":"USD","value":780000000.0,"xbrl_fact_id":"f-307"}],"statement":"Amgen Inc. (AMGN) reported Capex of USD 1,225,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/PaymentsToAcquirePropertyPlantAndEquipment","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-306"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/AccountsReceivableNetCurrent","change":0.06865203761755485,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Accounts receivable","label_en":"Accounts receivable","label_ko":"\ub9e4\ucd9c\ucc44\uad8c","period_type":"instant","xbrl_tag":"AccountsReceivableNetCurrent"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/AccountsReceivableNetCurrent","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-128","unit":"USD","value":10227000000.0,"xbrl_fact_id":"f-128"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-129","unit":"USD","value":9570000000.0,"xbrl_fact_id":"f-129"}],"statement":"Amgen Inc. (AMGN) reported Accounts receivable of USD 10,227,000,000 as of 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/AccountsReceivableNetCurrent","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-128"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/InventoryNet","change":-0.0008032128514056225,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Inventory","label_en":"Inventory","label_ko":"\uc7ac\uace0","period_type":"instant","xbrl_tag":"InventoryNet"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/InventoryNet","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-130","unit":"USD","value":6220000000.0,"xbrl_fact_id":"f-130"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-131","unit":"USD","value":6225000000.0,"xbrl_fact_id":"f-131"}],"statement":"Amgen Inc. (AMGN) reported Inventory of USD 6,220,000,000 as of 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/InventoryNet","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-130"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/CashAndCashEquivalentsAtCarryingValue","change":0.5323693723299375,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Cash","label_en":"Cash","label_ko":"\ud604\uae08","period_type":"instant","xbrl_tag":"CashAndCashEquivalentsAtCarryingValue"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/CashAndCashEquivalentsAtCarryingValue","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-126","unit":"USD","value":13989000000.0,"xbrl_fact_id":"f-126"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-127","unit":"USD","value":9129000000.0,"xbrl_fact_id":"f-127"}],"statement":"Amgen Inc. (AMGN) reported Cash of USD 13,989,000,000 as of 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/CashAndCashEquivalentsAtCarryingValue","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-126"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/LongTermDebtNoncurrent","change":0.037076292370762924,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Long-term debt","label_en":"Long-term debt","label_ko":"\uc7a5\uae30\ubd80\ucc44","period_type":"instant","xbrl_tag":"LongTermDebtNoncurrent"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/LongTermDebtNoncurrent","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-154","unit":"USD","value":51859000000.0,"xbrl_fact_id":"f-154"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-155","unit":"USD","value":50005000000.0,"xbrl_fact_id":"f-155"}],"statement":"Amgen Inc. (AMGN) reported Long-term debt of USD 51,859,000,000 as of 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/LongTermDebtNoncurrent","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-154"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/Assets","change":0.05578124655023955,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Total assets","label_en":"Total assets","label_ko":"\ucd1d\uc790\uc0b0","period_type":"instant","xbrl_tag":"Assets"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/Assets","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-144","unit":"USD","value":95639000000.0,"xbrl_fact_id":"f-144"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-145","unit":"USD","value":90586000000.0,"xbrl_fact_id":"f-145"}],"statement":"Amgen Inc. (AMGN) reported Total assets of USD 95,639,000,000 as of 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/Assets","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-144"},{"accession":"0000318154-26-000126","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000318154-26-000126/StockholdersEquity","change":0.2718171926006529,"cik":318154,"company":"Amgen Inc.","concept":{"label":"Total equity","label_en":"Total equity","label_ko":"\uc790\uae30\uc790\ubcf8","period_type":"instant","xbrl_tag":"StockholdersEquity"},"filed_at":"2026-08-04","filing_index_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/0000318154-26-000126-index.htm","filing_url":"https://aiswingx.com/f/0000318154-26-000126","form":"10-Q","id":"0000318154-26-000126/StockholdersEquity","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-178","unit":"USD","value":11688000000.0,"xbrl_fact_id":"f-178"},{"comparative":true,"instant":true,"period_end":"2026-03-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-186","unit":"USD","value":9190000000.0,"xbrl_fact_id":"f-186"}],"statement":"Amgen Inc. (AMGN) reported Total equity of USD 11,688,000,000 as of 2026-06-30 in its 10-Q (accession 0000318154-26-000126, filed 2026-08-04).","ticker":"AMGN","url":"https://aiswingx.com/n/0000318154-26-000126/StockholdersEquity","verify_url":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm#f-178"}],"limit":100,"note":"Inline XBRL facts as filed with the SEC, each with a permanent citation URL and a deep link to the figure in the filing document.","offset":0,"total":13}